Personalis, Inc. SEC filings PSNL

Personalis, Inc. has 555 filings in SEC EDGAR's recent list, going back to Aug 15, 2011. Its latest annual report, Form ARS, was filed on Apr 2, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (results of operations). The company's fiscal year ends on December 31.

Personalis, Inc. SEC filings
Form Description Filed Period
DEFM14A Filing Oct 21, 2026 —
DEFA14A Additional proxy material Apr 2, 2026 —
DEF 14A Proxy statement Apr 2, 2026 May 12, 2026
DEFA14A Additional proxy material Apr 3, 2025 —
DEF 14A Proxy statement Apr 3, 2025 May 16, 2025
DEFA14A Additional proxy material Apr 2, 2024 —
DEF 14A Proxy statement Apr 2, 2024 May 17, 2024
DEFA14A Additional proxy material Apr 5, 2023 —
DEF 14A Proxy statement Apr 5, 2023 May 17, 2023
DEFA14A Additional proxy material May 4, 2022 —
DEFA14A Additional proxy material Apr 1, 2022 —
DEF 14A Proxy statement Apr 1, 2022 May 17, 2022
DEFA14A Additional proxy material Apr 1, 2021 —
DEF 14A Proxy statement Apr 1, 2021 May 14, 2021
DEFA14A Additional proxy material Apr 3, 2020 —
DEF 14A Proxy statement Apr 3, 2020 May 15, 2020

Showing 16 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Services-Medical Laboratories (SIC 8071)
Listed as
PSNL (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Fremont, CA
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1527753

Other Services-Medical Laboratories companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.